Neonatal Screening for Metabolic and Endocrine Disorders-Reference-Cited by-同舟云学术

Neonatal Screening for Metabolic and Endocrine Disorders

Published:2011-01-10 Issue: Volume: Page:
ISSN:1866-0452
Container-title:Deutsches Ärzteblatt international
language:
Short-container-title:

Author:

Harms Erik,Olgemöller Bernhard

Publisher

Deutscher Arzte-Verlag GmbH

Subject

General Medicine

Reference21 articles.

1. Grosse SD, Khoury MJ, Greene CL, Crider KS, Pollitt RJ: The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: An update. Genet Med 2006; 8: 205–12.

2. Ogier de Baulny H, Saudubray JM: Branched-chain organic acidurias. Semin Neonatol 2002; 7: 65–74.

3. Bickel H, Gerrard J, Hickmans EM: Preliminiary communication: Influence of phenylalanine intake on phenylketonuria. Lancet 1953; 262: 812–3.

4. Guthrie R, Susi A: A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32: 338–42.

5. Klett M, Schönberg D: Neugeborenen-Hypothyreose-Screening in der Bundesrepublik Deutschland: Ergebnisse einer Umfrage. Dtsch med Wochenschr 1981; 106: 6–12.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newborn Metabolic and Endocrine Disease Screening Program: Example of Giresun Province Between 2015 and 2020;The Journal of Tepecik Education and Research Hospital;2023-08-14

2. Neugeborenen-Screening in Deutschland;Pädiatrie up2date;2023-06

3. Global impact of COVID-19 on newborn screening programmes;BMJ Global Health;2022-03

4. Ausschlussdiagnostik dringlich zu behandelnder Ursachen einer Cholestase;Monatsschrift Kinderheilkunde;2021-05-22

5. Voltammetric Determination of Phenylalanine Using Chemically Modified Screen-Printed Based Sensors;Chemosensors;2020-11-12